Skip to main content
Clinical Trials/ITMCTR1900002284
ITMCTR1900002284
Recruiting
Phase 1

Research for the central nervous regulation mechanism of transcutaneous auricular vagus nerve stimulation in the treatment of patients with chronic insomnia based on fMRI

Department of Radiology,The Second Clinical College of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine)0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Radiology,The Second Clinical College of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine)
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Department of Radiology,The Second Clinical College of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine)

Eligibility Criteria

Inclusion Criteria

  • 1\. Meeting the diagnostic criteria of chronic insomnia in International Classification of Sleep Disorders (Third Edition):
  • (1\) The patient complained that it was difficult to fall asleep or maintain sleep, wake up early, and dissatisfied with sleep quality;
  • (2\) Patients with daytime fatigue, sleepiness, impaired attention and memory, emotional instability and prone to irritation;
  • (3\) Patients have difficulties in falling asleep and can not be explained simply by poor sleeping environment (such as darkness, safety and comfort);
  • (4\) The patient's sleep disorder or related daytime symptoms occured at least 3 times a week and lasted for more than 3 months;E.The cause of insomnia in patients cannot be explained by any other disea.
  • 2\. Male or female aged 18 to 70 years old;
  • 3\. The patients' symptom scores, Pittsburgh sleep score \> 7 points, Insomnia severity index \>14 points, 24 Hamilton depression score \< 35 points (more than 20 points may have depression, greater than 35 points for severe depression), Hamilton Anxiety Scale\< 29 points, Self\-evaluation Anxiety Scale(SAS) standard score\< 50 points , Self\-rating Depression Scale (SDS) standard score\< 52 points;
  • 4\. The patients agreed to participate in the clinical research and sign the informed consent. They have a certain level of education to cooperate with the the relevant insomnia/anxiety/depression score scale.

Exclusion Criteria

  • 1\. Patients with cardiovascular, digestive, liver, kidney, hematopoietic system and other serious primary diseases; patients with diseases that might be in danger through vagal nerve stimulation, such as heart failure, hyperthyroidism.
  • 2\. Patients have a history of alcoholism, drug abuse, mental illness or dementia;
  • 3\. Patients with allergy, damage or inflammation at the therapeutic site;
  • 4\. Pregnant or lactating women;
  • 5\. Patients took anticholinergics, non\-steroidal anti\-inflammatory drugs and hormone drugs recently. Patients are taking anti\-depressants to inhibit the activity of the cerebral cortex nervous system currently;
  • 6\. There are contraindications of magnetic resonance examination such as metal implants and claustrophobia;
  • 7\. Patients participating in other clinical trials in the past six months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
Study on the central-peripheral regulation mechanism of ocular acupuncture kinesitherapy for post-stroke dyskinesiapost-stroke dyskinesia
ITMCTR2200006052Hospital of Chengdu University of Traditional Chinese Medicine
Active, not recruiting
Not Applicable
A Randomized Pilot Study on Central Nervous System (CNS) Prophylaxiswith Liposome-Encapsulated Cytarabine (DepoCyte) in a Population of Adult Patientswith Acute Lymphoblastic Leukemia (ALL) Treated with an Updated and Lineage-TargetedMinimal Residual Disease (MRD)-Oriented Postremission Strategy. - NILG-ALL 10/072. Diagnosis of untreated ALL with B-/T-precursor phenotype or B/T-LL, either de novo or secondary to chemo-radiotherapy for other cancer.MedDRA version: 9.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disorders
EUCTR2007-006652-19-ITILG
Recruiting
Not Applicable
Antiprmechanisms of central nervous system by multimodal magnetic resonance imaging in mind-oriented acupuncture therapy for treating chronic spontaneous urticariachronic spontaneous urticaria
ITMCTR2100004564Guang'anmen Hospital, China Academy of Chinese Medicine Sciences
Recruiting
Not Applicable
Analysis of functional changes in the central nervous system in post-COVID-19 syndromePost-COVID-19 syndrome
JPRN-UMIN000046087Pain Center, Chiba Medical Center, Teikyo University80
Completed
Not Applicable
Study Comparing Cortical Function and Dysfunction Tests in Low Back PainChronic Nonspecific Low Back Pain
NCT00924495Kuopio University Hospital80